Boston Scientific announces conference call discussing first quarter 2026 results
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will webcast a conference call to discuss its first quarter ended March 31, 2026 results on April 22, 2026 at 8:00 a.m. ET.
The call will be hosted by Mike Mahoney, chairman and CEO, and Jon Monson, EVP and CFO. A news release with results will be issued before the call; live webcast and replay available at the company's investor site.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
BSX is down 1.43% with elevated volume. All 5 major peers (SYK, MDT, EW, ABT, PHG) also show declines between -0.21% and -3.01%, indicating a broad Medical Devices downdraft rather than a BSX‑specific move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 02 | Earnings & conference plan | Neutral | -0.7% | Outlined JPM conference appearance and Q4/FY 2025 earnings call timing. |
| Sep 02 | Investor day & Q3 call | Neutral | +1.1% | Announced 2025 Investor Day and Q3 2025 earnings conference call schedule. |
| Jul 01 | Q2 2025 call setup | Neutral | -2.5% | Set date and time for Q2 2025 earnings call and webcast access. |
| Apr 01 | Q1 2025 call setup | Neutral | +0.4% | Scheduled Q1 2025 results call with leadership and webcast details. |
| Jan 02 | JPM & Q4 2024 call | Neutral | +0.1% | Announced JPM conference participation and Q4 2024 earnings call timing. |
Similar "conferences,earnings" scheduling announcements have historically led to modest share moves, with a slight average negative reaction of -0.32% over the past five tagged events.
Over the past several quarters, Boston Scientific has repeatedly issued combined "conferences,earnings" announcements outlining participation in major healthcare conferences and scheduling quarterly earnings calls. Prior releases on Jan 2, 2025, Apr 1, 2025, Jul 1, 2025, Sep 2, 2025, and Jan 2, 2026 all followed the same template: setting dates and times, naming senior presenters, and confirming that webcasts and replays would be available. Price reactions around these events have been modest, with single‑day moves ranging roughly between about -2.45% and 1.10%, suggesting these notices are treated as routine housekeeping rather than major catalysts.
Historical Comparison
In the past tagged "conferences,earnings" announcements, BSX saw an average move of -0.32% on the day, with generally modest single‑day reactions around routine scheduling news.
The pattern shows a consistent cadence of quarterly earnings calls paired with major conference appearances, reinforcing a stable investor‑relations playbook rather than signaling step‑change corporate developments.
Market Pulse Summary
This announcement sets logistics for Boston Scientific’s Q1 2026 earnings discussion, confirming that results for the quarter ended March 31, 2026 will be released on April 22, 2026 with an 8:00 a.m. ET webcast and replay. It mirrors prior "conferences,earnings" notices that averaged a modest -0.32% price move, suggesting these are treated as routine. Investors may focus on the forthcoming financial release, recent acquisition-related filings, and prior clinical data updates as the more material catalysts.
AI-generated analysis. Not financial advice.
A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2026-results-302727378.html
SOURCE Boston Scientific Corporation
FAQ
When will Boston Scientific (BSX) discuss Q1 2026 results?
Who will host Boston Scientific's (BSX) Q1 2026 conference call?
Where can investors access Boston Scientific (BSX) April 22, 2026 webcast?
Will Boston Scientific (BSX) release Q1 2026 financial results before the call?
What topics will Boston Scientific (BSX) cover on the April 22, 2026 call?